1. Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) 4th meeting: Lessons learned from first clinical trials
- Author
-
Franquesa, Marcella, Hoogduijn, Martin J., Reinders, Marlies E., Eggenhofer, Elke, Engela, Anja U., Mensah, Fane K., Torras, Joan, Pileggi, Antonello, van Kooten, Cees, Mahon, Bernard, Detry, Oliver, Popp, Felix C., Benseler, Volker, Casiraghi, Federica, Johnson, Christian, Ancans, Janis, Fillenberg, Barbara, delaRosa, Olga, Aran, Josep M., Roemeling-vanRhijn, Marieke, Pinxteren, Jef, Perico, Norberto, Gotti, Eliana, Christ, Bruno, Reading, James, Introna, Martino, Deans, Robert, Shagidulin, Murat, Farré, Ramon, Rambaldi, Alessandro, Sanchez-Fueyo, Albert, Obermajer, Natasha, Pulin, Andrey, Dor, Frank J.M.F., Portero-Sanchez, Isabel, Baan, Carla C., Rabelink, Ton J., Remuzzi, Giuseppe, Betjes, Michiel G.H., Dahlke, Marc H., and Grinyó, Josep M.
- Subjects
Article - Abstract
The 4th expert meeting of the MiSOT (Mesenchymal Stem Cells in Solid Organ Transplantation) Consortium took place in Barcelona on the 19th and 20th of October 2012. This meeting focused on the translation of pre-clinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells (MSC) as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of MSC and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.
- Published
- 2013